CRM PZ Cormay S.A.
PZ Cormay S.A., a diagnostic company, provides IVD solutions in Poland and internationally. The company offers analyzers, reagents, cleaning liquids, calibrators, control materials, patterns, and agglutination tests. It also provides analyzers, test strips, inspections, and calibration strips. In addition, the company offers parasitology, such as Paragreen Mini-System, a specialized device for concentrating and preserving stool samples, as well as veterinary medicines. Further, it provides immunochemistry, including SNIBE, MINDRAY, and DIESSE, as well as molecular biology, such as RT-PCR systems, systems for isolating genetic material, workstations, RT-PCR reagent kits, and nucleic acid isolation reagent kits. Additionally, the company offers sampling comprising blood and urine samples and supporting materials, as well as Sentimag systems, Magtrace markers, Magseed Markers, and surgical instruments, as well as HPLC systems, point of care diagnostics, and integrated systems. The company was founded in 1985 and is based in Lomianki, Poland.…
Industry Peers
Scientific & Technical InstrumentsKey Statistics
About PZ Cormay (WSE: CRM)
›
PZ Cormay (WSE: CRM) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 220 employees.
The shares were at 0.4690 PLN on 19 November 2026, up 14.4% over 52 weeks. Its 52-week range is 0.3380 PLN to 0.8900 PLN: the price is 47.3% below the high and 38.8% above the low.
Its market capitalisation is 39.49M PLN.
PZ Cormay reports return on equity of -9.1%, an operating margin of -2.3% and revenue up 19.3% year over year.
Its debt exceeds its cash by 10.31M PLN, a debt-to-equity ratio of 0.22. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.